Chimerix Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
CMRX Nasdaq 8731 http://www.chimerix.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Chimerix Inc

12 Cheap Healthcare Stocks to Buy in 2023 - Mar 29th, 2023 2:13 pm
Chimerix (CMRX) Loses -24.68% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Mar 29th, 2023 1:35 pm
Chimerix, Inc. (NASDAQ:CMRX) Q4 2022 Earnings Call Transcript - Mar 6th, 2023 10:51 am
The Top 7 Growth Stocks in Biotech - Mar 3rd, 2023 11:57 pm
Q4 2022 Chimerix Inc Earnings Call - Mar 3rd, 2023 3:10 am
Chimerix Reports Fourth Quarter and Year End 2022 Financial Results and Provides Operational Update - Mar 2nd, 2023 12:00 pm
Chimerix to Present at Cowen and Company 43rd Annual Health Care Conference - Feb 28th, 2023 9:05 pm
Chimerix to Report Fourth Quarter and Year End 2022 Financial Results and Provide an Operational Update on March 2, 2023 - Feb 23rd, 2023 12:00 pm
With 53% ownership of the shares, Chimerix, Inc. (NASDAQ:CMRX) is heavily dominated by institutional owners - Feb 17th, 2023 2:04 pm
7 Overlooked Value Stocks That Could Outperform the Market - Feb 13th, 2023 10:55 pm
The 7 Best Biotech Stocks to Buy for February 2023 - Feb 7th, 2023 6:51 pm
The 7 Most Undervalued Biotech Stocks to Buy in February 2023 - Feb 2nd, 2023 7:19 pm
16 Stocks with the Lowest PE Ratio - Jan 19th, 2023 3:49 pm
Chimerix to Present at 41st Annual J.P. Morgan Healthcare Conference - Jan 5th, 2023 12:00 pm
2022 Year in Review: Layoffs hit Triangle biotech, pharma companies - Dec 27th, 2022 7:53 pm
Durham drugmaker to cut workforce by 25%, focus on new cancer drug - Dec 12th, 2022 6:41 pm
Chimerix Announces Successful Launch of ONC201 Phase 3 ACTION Study at Society for Neuro-Oncology Conference and Provides Operational Update - Dec 8th, 2022 10:00 pm
Chimerix (CMRX) Upgraded to Buy: What Does It Mean for the Stock? - Nov 29th, 2022 5:00 pm
Chimerix Responds to Rubric Capital Management - Nov 10th, 2022 9:30 pm
Rubric Capital Management Sends Letter to Chimerix Board of Directors - Nov 10th, 2022 2:00 pm